Niki I, Okazaki K, Saitoh M, Niki A, Niki H, Tamagawa T, Iguchi A, Hidaka H
Department of Geriatrics, Nagoya University School of Medicine, Japan.
Biochem Biophys Res Commun. 1993 Feb 26;191(1):255-61. doi: 10.1006/bbrc.1993.1210.
Roles of Ca/calmodulin-dependent protein kinase II (Ca/CaM kinase II) and myosin light chain kinase (MLCK) in insulin release from rat pancreatic islets were investigated. Western blotting using polyclonal antibody to Ca/CaM kinase II suggested the presence of this kinase in the pancreatic islets. Extracts of pancreatic islets phosphorylated exogenous myosin light chain, which was inhibited by ML-9, an inhibitor of MLCK. KN-62 and KN-93, inhibitors of Ca/CaM kinase II, and ML-9 at microM concentrations inhibited insulin release stimulated by glucose or high K+. KN-62 and KN-93, but not ML-9, inhibited insulin release increased by glucose and forskolin, an activator of adenylate cyclase. These inhibitors had no effect on insulin release evoked by 12-O-tetradecanoyl phorbol-13-acetate, an activator of Ca(2+)-sensitive, diacylglycerol-dependent protein kinase. These results suggest that Ca/CaM kinase II and MLCK may participate in the control of insulin release.
研究了钙/钙调蛋白依赖性蛋白激酶II(Ca/CaM激酶II)和肌球蛋白轻链激酶(MLCK)在大鼠胰岛胰岛素释放中的作用。使用抗Ca/CaM激酶II多克隆抗体的蛋白质印迹法表明该激酶存在于胰岛中。胰岛提取物使外源性肌球蛋白轻链磷酸化,这被MLCK的抑制剂ML-9所抑制。微摩尔浓度的Ca/CaM激酶II抑制剂KN-62和KN-93以及ML-9抑制了葡萄糖或高钾刺激的胰岛素释放。KN-62和KN-93而非ML-9抑制了由葡萄糖和腺苷酸环化酶激活剂福斯可林增加的胰岛素释放。这些抑制剂对由12-O-十四烷酰佛波醇-13-乙酸酯(一种钙敏感、二酰基甘油依赖性蛋白激酶的激活剂)诱发的胰岛素释放没有影响。这些结果表明Ca/CaM激酶II和MLCK可能参与胰岛素释放的调控。